MoonLake Immunotherapeutics

Q3 2024 13F Holders

Symbol
MLTX
CUSIP
61559X104
Type
Equity
Class
CLASS A ORD
Num filings
119
Total reported value, excl. options
$3.13 B
Manager Report Date Value ($000) Shares Option Type